Need Help?

Whole Exome Sequencing of a Melanoma Patient with Acquired Resistance to MEK plus CDK4/6 Inhibition

Longitudinal biopsies from a melanoma patient who initially responded to MEK plus CDK4/6 inhibitor therapy were whole exome sequenced to identify potential resistance mutations. The biopsies included normal tissue, pre-treatment, on-treatment, and several post-resistance timepoints.

Request Access

MD Anderson DAA

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001002846 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00001880019 bam 14.9 GB
EGAF00001880020 bam 21.1 GB
EGAF00001880021 bam 22.9 GB
EGAF00001880022 bam 33.6 GB
EGAF00001880023 bam 34.1 GB
EGAF00001880024 bam 24.9 GB
6 Files (151.5 GB)